Provided by Tiger Fintech (Singapore) Pte. Ltd.

Harte-Hanks

4.55
+0.03000.66%
Post-market: 4.550.00000.00%16:05 EDT
Volume:12.37K
Turnover:55.75K
Market Cap:33.48M
PE:-1.11
High:4.69
Open:4.40
Low:4.27
Close:4.52
Loading ...

Oppenheimer doesn’t see threat to Gilead estimates after HHS plans for HIV cuts

TIPRANKS
·
Yesterday

Here's Why We're Watching Harte Hanks' (NASDAQ:HHS) Cash Burn Situation

Simply Wall St.
·
Yesterday

HHS, FDA announce set of actions and initiatives focused on infant formula

TIPRANKS
·
Yesterday

Harte Hanks Q4 Revenue USD 47.129 Million

THOMSON REUTERS
·
17 Mar

Harte Hanks Reports Fourth Quarter and Fiscal 2024 Full-Year Results

ACCESS Newswire
·
17 Mar

An Ozempic successor falls short, Eli Lilly's GLP-1 pill, and senators grill RFK: Pharma news roundup

Quartz
·
14 Mar

President Trump and Medicare: 3 Things You Should Know

Motley Fool
·
13 Mar

Market Chatter: PepsiCo, General Mills Among Food Brands Set to Meet With HHS Secretary

MT Newswires Live
·
10 Mar

Measles Outbreak: NV-387 Promises To Be An Effective Drug To Treat Patients; We are Ready To Work With HHS, Says NanoViricides President Dr. Anil Diwan

ACCESS Newswire
·
04 Mar

HHS increasing scrutiny of vaccines under RFK Jr., WSJ reports

TIPRANKS
·
04 Mar

GeoVax Highlights the Critical Role of MVA-Based Vaccines in U.S. Biodefense Strategy

NewMediaWire
·
03 Mar

Doximity and Krispy Kreme have been highlighted as Zacks Bull and Bear of the Day

Zacks
·
28 Feb

Bear of the Day: Krispy Kreme (DNUT)

Zacks
·
28 Feb

Moderna Shares Fall After Reports of HHS Review of Bird Flu Vaccine Contract -- WSJ

Dow Jones
·
28 Feb

Moderna's stock stumbles on report HHS is reviewing a $590 million bird-flu-vaccine award

Dow Jones
·
28 Feb

Moderna Shares Fall on Report HHS Is Reviewing Bird Flu Vaccine Contract -- Barrons.com

Dow Jones
·
27 Feb